17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.

BACKGROUND: The accumulation and aggregation of alpha-synuclein in nerve cells and glia are characteristic features of a number of neurodegenerative diseases termed synucleinopathies. alpha-Synuclein is a highly soluble protein which in a nucleation dependent process is capable of self-aggregation....

Full description

Bibliographic Details
Main Authors: Michael Riedel, Olaf Goldbaum, Lisa Schwarz, Sebastian Schmitt, Christiane Richter-Landsberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2807466?pdf=render
id doaj-bb7b239376324c9e8c063a6d91b3e114
record_format Article
spelling doaj-bb7b239376324c9e8c063a6d91b3e1142020-11-25T01:47:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-0151e875310.1371/journal.pone.000875317-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.Michael RiedelOlaf GoldbaumLisa SchwarzSebastian SchmittChristiane Richter-LandsbergBACKGROUND: The accumulation and aggregation of alpha-synuclein in nerve cells and glia are characteristic features of a number of neurodegenerative diseases termed synucleinopathies. alpha-Synuclein is a highly soluble protein which in a nucleation dependent process is capable of self-aggregation. The causes underlying aggregate formation are not yet understood, impairment of the proteolytic degradation systems might be involved. METHODOLOGY/PRINCIPAL FINDINGS: In the present study the possible aggregate clearing effects of the geldanamycin analogue 17-AAG (17-(Allylamino)-17-demethoxygeldanamycin) was investigated. Towards this, an oligodendroglial cell line (OLN-93 cells), stably expressing human alpha-synuclein (A53T mutation) was used. In these cells small punctate aggregates, not staining with thioflavine S, representing prefibrillary aggregates, occur characteristically. Our data demonstrate that 17-AAG attenuated the formation of alpha-synuclein aggregates by stimulating macroautophagy. By blocking the lysosomal compartment with NH(4)Cl the aggregate clearing effects of 17-AAG were abolished and alpha-synuclein deposits were enlarged. Analysis of LC3-II immunoreactivity, which is an indicator of autophagosome formation, further revealed that 17-AAG led to the recruitment of LC3-II and to the formation of LC3 positive puncta. This effect was also observed in cultured oligodendrocytes derived from the brains of newborn rats. Inhibition of macroautophagy by 3-methyladenine prevented 17-AAG induced occurrence of LC3 positive puncta as well as the removal of alpha-synuclein aggregates in OLN-A53T cells. CONCLUSIONS: Our data demonstrate for the first time that 17-AAG not only causes the upregulation of heat shock proteins, but also is an effective inducer of the autophagic pathway by which alpha-synuclein can be removed. Hence geldanamycin derivatives may provide a means to modulate autophagy in neural cells, thereby ameliorating pathogenic aggregate formation and protecting the cells during disease and aging.http://europepmc.org/articles/PMC2807466?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Michael Riedel
Olaf Goldbaum
Lisa Schwarz
Sebastian Schmitt
Christiane Richter-Landsberg
spellingShingle Michael Riedel
Olaf Goldbaum
Lisa Schwarz
Sebastian Schmitt
Christiane Richter-Landsberg
17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
PLoS ONE
author_facet Michael Riedel
Olaf Goldbaum
Lisa Schwarz
Sebastian Schmitt
Christiane Richter-Landsberg
author_sort Michael Riedel
title 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
title_short 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
title_full 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
title_fullStr 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
title_full_unstemmed 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
title_sort 17-aag induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2010-01-01
description BACKGROUND: The accumulation and aggregation of alpha-synuclein in nerve cells and glia are characteristic features of a number of neurodegenerative diseases termed synucleinopathies. alpha-Synuclein is a highly soluble protein which in a nucleation dependent process is capable of self-aggregation. The causes underlying aggregate formation are not yet understood, impairment of the proteolytic degradation systems might be involved. METHODOLOGY/PRINCIPAL FINDINGS: In the present study the possible aggregate clearing effects of the geldanamycin analogue 17-AAG (17-(Allylamino)-17-demethoxygeldanamycin) was investigated. Towards this, an oligodendroglial cell line (OLN-93 cells), stably expressing human alpha-synuclein (A53T mutation) was used. In these cells small punctate aggregates, not staining with thioflavine S, representing prefibrillary aggregates, occur characteristically. Our data demonstrate that 17-AAG attenuated the formation of alpha-synuclein aggregates by stimulating macroautophagy. By blocking the lysosomal compartment with NH(4)Cl the aggregate clearing effects of 17-AAG were abolished and alpha-synuclein deposits were enlarged. Analysis of LC3-II immunoreactivity, which is an indicator of autophagosome formation, further revealed that 17-AAG led to the recruitment of LC3-II and to the formation of LC3 positive puncta. This effect was also observed in cultured oligodendrocytes derived from the brains of newborn rats. Inhibition of macroautophagy by 3-methyladenine prevented 17-AAG induced occurrence of LC3 positive puncta as well as the removal of alpha-synuclein aggregates in OLN-A53T cells. CONCLUSIONS: Our data demonstrate for the first time that 17-AAG not only causes the upregulation of heat shock proteins, but also is an effective inducer of the autophagic pathway by which alpha-synuclein can be removed. Hence geldanamycin derivatives may provide a means to modulate autophagy in neural cells, thereby ameliorating pathogenic aggregate formation and protecting the cells during disease and aging.
url http://europepmc.org/articles/PMC2807466?pdf=render
work_keys_str_mv AT michaelriedel 17aaginducescytoplasmicalphasynucleinaggregateclearancebyinductionofautophagy
AT olafgoldbaum 17aaginducescytoplasmicalphasynucleinaggregateclearancebyinductionofautophagy
AT lisaschwarz 17aaginducescytoplasmicalphasynucleinaggregateclearancebyinductionofautophagy
AT sebastianschmitt 17aaginducescytoplasmicalphasynucleinaggregateclearancebyinductionofautophagy
AT christianerichterlandsberg 17aaginducescytoplasmicalphasynucleinaggregateclearancebyinductionofautophagy
_version_ 1725014981090476032